Literature DB >> 15194242

Estimating hospital admissions due to rotavirus gastroenteritis from hospital episode statistics.

F Andrew I Riordan1, Theresa Quigley.   

Abstract

OBJECTIVES: To determine the proportion of hospital admissions, in children < 5 years old, coded for intestinal infectious disease or non-infectious gastroenteritis, using ICD-10 codes, that were due to rotavirus infection. To assess how many children admitted with rotavirus gastroenteritis were given the specific ICD-10 code (A080) for this disease.
METHODS: Sixteen-month prospective, observational study of children < 5 years old, admitted to district general hospital with: acute gastroenteritis (> or =3 loose stools/day), proven rotavirus infection and those coded as intestinal infectious disease or non-infectious gastroenteritis.
RESULTS: Four hundred and twenty children < 5 years old were admitted with acute gastroenteritis. Rotavirus was detected in 170 children's stools. Acute rotavirus gastroenteritis accounted for 81/397 (20%) children coded as having non-infectious gastroenteritis and 32/81 (40%) coded for intestinal infectious disease. Only 18 children were coded for rotavirus gastroenteritis. Potentially preventable rotavirus gastroenteritis occurred in 122 children; 78 coded as non-infectious gastroenteritis (20%) and 26 coded for intestinal infectious disease (34%).
CONCLUSIONS: The proportion of children coded with diarrhoeal diseases and found to have rotavirus is less than previously estimated. Using the specific code for rotavirus infection to estimate hospital admissions would be a gross underestimate. Hospital episode statistics cannot reliably estimate the burden of disease due to rotavirus.

Entities:  

Mesh:

Year:  2004        PMID: 15194242     DOI: 10.1016/j.jinf.2004.02.006

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  7 in total

Review 1.  The paediatric burden of rotavirus disease in Europe.

Authors: 
Journal:  Epidemiol Infect       Date:  2006-04-04       Impact factor: 2.451

2.  Comparison of administrative data with the Association of Coloproctology of Great Britain and Ireland (ACPGBI) colorectal cancer database.

Authors:  Mohammed Garout; Henry S Tilney; Paris P Tekkis; Paul Aylin
Journal:  Int J Colorectal Dis       Date:  2007-10-25       Impact factor: 2.571

3.  Epidemiological and clinical features of rotavirus among children younger than 5 years of age hospitalized with acute gastroenteritis in Northern Italy.

Authors:  Gianvincenzo Zuccotti; Fabio Meneghin; Dario Dilillo; Luisa Romanò; Roberta Bottone; Cecilia Mantegazza; Roberto Giacchino; Roberto Besana; Giuseppe Ricciardi; Andrea Sterpa; Nicola Altamura; Massimo Andreotti; Giovanni Montrasio; Luigi Macchi; Anna Pavan; Sara Paladini; Alessandro Zanetti; Giovanni Radaelli
Journal:  BMC Infect Dis       Date:  2010-07-22       Impact factor: 3.090

Review 4.  Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review.

Authors:  Isla Ogilvie; Hanane Khoury; Mireille M Goetghebeur; Antoine C El Khoury; Carlo Giaquinto
Journal:  BMC Infect Dis       Date:  2012-03-19       Impact factor: 3.090

5.  Incidence and cost of rotavirus hospitalizations in Denmark.

Authors:  Thea Kølsen Fischer; Nete Munk Nielsen; Jan Wohlfahrt; Anders Paerregaard
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

6.  Impact of rotavirus vaccination in Australian children below 5 years of age: a database study.

Authors:  Annmarie Pendleton; Maja Galic; Christopher Clarke; Su Peing Ng; Emilio Ledesma; Gunasekaran Ramakrishnan; Yanfang Liu
Journal:  Hum Vaccin Immunother       Date:  2013-06-03       Impact factor: 3.452

7.  Rotavirus vaccine impact and socioeconomic deprivation: an interrupted time-series analysis of gastrointestinal disease outcomes across primary and secondary care in the UK.

Authors:  Daniel Hungerford; Roberto Vivancos; Jonathan M Read; Miren Iturriza-Gόmara; Neil French; Nigel A Cunliffe
Journal:  BMC Med       Date:  2018-01-29       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.